Molecular-Level Simulation of Pandemic Influenza Glycoproteins

Part of the Methods in Molecular Biology book series (MIMB, volume 819)


Computational simulation of pandemic diseases provides important insight into many disease features that may benefit public health. This is especially true for the influenza virus, a continuing global pandemic threat. Molecular or atomic-level investigation of influenza has predominantly focused on the two major virus glycoproteins, neuraminidase (NA) and hemagglutinin (HA). In this chapter, we walk the readers through major considerations for studying pandemic influenza glycoproteins, from choosing the most useful choice of system(s) to avoiding common pitfalls in experimental design and execution. While a brief discussion of several potential simulation and docking techniques is presented, we emphasize molecular dynamics (MD) and Brownian dynamics (BD) simulation techniques and molecular docking, within the context of biologically outstanding questions in influenza research.

Key words

Pandemic diseases Computational biology Influenza Neuraminidase Hemagglutinin Molecular dynamics simulations Brownian dynamics simulations Binding free energy estimates Docking Antiviral design 



This work was funded by the National Institutes of Health (NIH) through the NIH Director’s New Innovator Award Program, 1-DP2-OD007237 and a NIH Career Transition Award 1-K22-AI081901 to R.E.A. W.W.L. is funded in part by NIH P41 RR08605.


  1. 1.
    Colman, P. (2006) Structure-Based Drug Discovery: An Overview, Royal Society of Chemistry.Google Scholar
  2. 2.
    Itzstein, M. v., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Phan, T. V., Smythe, M. L., White, H. F., Oliver, S. W., Colman, P. M., Varghese, J. N., Ryan, D. M., Woods, J. M., Bethell, R. C., Hotham, V. J., Cameron, J. M., and Penn, C. R. (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication, Nature 363, 418–423.Google Scholar
  3. 3.
    Newhouse, E. I., Xu, D., Markwick, P. R. L., Amaro, R. E., Pao, H. C., Wu, K. J., Alam, M., McCammon, J. A., and Li, W. W. (2009) Mechanism of Glycan Receptor Recognition and Specificity Switch for Avian, Swine, and Human Adapted Influenza Virus Hemagglutinins: A Molecular Dynamics Perspective, Journal of the American Chemical Society 131, 17430–17442.PubMedCrossRefGoogle Scholar
  4. 4.
    Amaro, R. E., Minh, D. D., Cheng, L. S., Lindstrom, W. M., Jr., Olson, A. J., Lin, J. H., Li, W. W., and McCammon, J. A. (2007) Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design, J Am Chem Soc 129, 7764–7765.PubMedCrossRefGoogle Scholar
  5. 5.
    Udommaneethanakit, T., Rungrotmongkol, T., Bren, U., Frecer, V., and Stanislav, M. (2009) Dynamic Behavior of Avian Influenza A Virus Neuraminidase Subtype H5N1 in Complex with Oseltamivir, Zanamivir, Peramivir, and Their Phosphonate Analogues, Journal of Chemical Information and Modeling 49, 2323–2332.PubMedCrossRefGoogle Scholar
  6. 6.
    Kasson, P. M., Ensign, D. L., and Pande, V. S. (2009) Combining Molecular Dynamics with Bayesian Analysis To Predict and Evaluate Ligand-Binding Mutations in Influenza Hemagglutinin, Journal of the American Chemical Society 131, 11338–11340.PubMedCrossRefGoogle Scholar
  7. 7.
    Smondyrev, A. M., and Voth, G. A. (2002) Molecular Dynamics Simulation of Proton Transport through the Influenza A Virus M2 Channel, Biophysical Journal 83, 1987–1996.PubMedCrossRefGoogle Scholar
  8. 8.
    Grienke, U., Schmidtke, M., Kirchmair, J., Pfarr, K., Wutzler, P., DuÃàrrwald, R., Wolber, G., Liedl, K. R., Stuppner, H., and Rollinger, J. M. (2009) Antiviral Potential and Molecular Insight into Neuraminidase Inhibiting Diarylheptanoids from Alpinia katsumadai, Journal of Medicinal Chemistry 53, 778–786.CrossRefGoogle Scholar
  9. 9.
    Park, J. W., and Jo, W. H. (2009) Infiltration of Water Molecules into the Oseltamivir-Binding Site of H274Y Neuraminidase Mutant Causes Resistance to Oseltamivir, Journal of Chemical Information and Modeling 49, 2735–2741.PubMedCrossRefGoogle Scholar
  10. 10.
    Smith, B. J., McKimm-Breshkin, J. L., McDonald, M., Fernley, R. T., Varghese, J. N., and Colman, P. M. (2002) Structural Studies of the Resistance of Influenza Virus Neuraminidase to Inhibitors, Journal of Medicinal Chemistry 45, 2207–2212.PubMedCrossRefGoogle Scholar
  11. 11.
    Le, L., Lee, E. H., Hardy, D. J., Truong, T. N., and Schulten, K. (2010) Molecular Dynamics Simulations Suggest that Electrostatic Funnel Directs Binding of Tamiflu to Influenza N1 Neuraminidases, PLoS Comput Biol 6, e1000939.CrossRefGoogle Scholar
  12. 12.
    Michel, J., Verdonk, M. L., and Essex, J. W. (2006) Protein-Ligand Binding Affinity Predictions by Implicit Solvent Simulations: A Tool for Lead Optimization?, Journal of Medicinal Chemistry 49, 7427–7439.PubMedCrossRefGoogle Scholar
  13. 13.
    Amaro, R. E., Cheng, X., Ivanov, I., Xu, D., and McCammon, J. A. (2009) Characterizing Loop Dynamics and Ligand Recognition in Human- and Avian-type Influenza Neuraminidases via Generalized Born Molecular Dynamics and End-point Free Energy Calculations, J Am Chem Soc 131, 4702–4709.PubMedCrossRefGoogle Scholar
  14. 14.
    Sung, J. C., Wynsberghe, A. W. V., Amaro, R. E., Li, W. W., and McCammon, J. A. (2010) Role of Secondary Sialic Acid Binding Sites in Influenza N1 Neuraminidase, Journal of the American Chemical Society 132, 2883–2885.PubMedCrossRefGoogle Scholar
  15. 15.
    Cheng, L. S., Amaro, R. E., Xu, D., Li, W. W., Arzberger, P., and McCammon, J. A. (2008) Ensemble-based Virtual Screening Reveals Potential Novel Antiviral Compounds for Avian Influenza Neuraminidase, J Med Chem 51, 3878–3894.PubMedCrossRefGoogle Scholar
  16. 16.
    D’Ursi, P., Chiappori, F., Merelli, I., Cozzi, P., Rovida, E., and Milanesi, L. (2009) Virtual screening pipeline and ligand modelling for H5N1 neuraminidase, Biochemical and Biophysical Research Communications 383, 445–449.PubMedCrossRefGoogle Scholar
  17. 17.
    An, J., Lee, D. C. W., Law, A. H. Y., Yang, C. L. H., Poon, L. L. M., Lau, A. S. Y., and Jones, S. J. M. (2009) A Novel Small-Molecule Inhibitor of the Avian Influenza H5N1 Virus Determined through Computational Screening against the Neuraminidase, Journal of Medicinal Chemistry 52, 2667–2672.PubMedCrossRefGoogle Scholar
  18. 18.
    Lin, C. H., Chang, T. T., Sun, M. F., Chen, H. Y., Tsai, F. J., Chang, K. L., Fisher, M., and Chen, C. Y. C. (2011) Potent Inhibitor Design Against H1N1 Swine Influenza: Structure-based and Molecular Dynamics Analysis for M2 Inhibitors from Traditional Chinese Medicine Database, J. Biomol Struct Dyn 28, 471–482.PubMedGoogle Scholar
  19. 19.
    Garcia-Sosa, A. T., Sild, S., and Maran, U. (2008) Design of Multi-Binding-Site Inhibitors, Ligand Efficiency, and Consensus Screening of Avian Influenza H5N1 Wild-Type Neuraminidase and of the Oseltamivir-Resistant H274Y Variant, Journal of Chemical Information and Modeling 48, 2074–2080.PubMedCrossRefGoogle Scholar
  20. 20.
    Masukawa, K., Kollman, P. A., and Kuntz, I. D. (2003) Investigation of Neuraminidase-Substrate Recognition Using Molecular Dynamics and Free Energy Calculations, Journal of Medicinal Chemistry 46, 5628–5637.PubMedCrossRefGoogle Scholar
  21. 21.
    Chachra, R., and Rizzo, R. C. (2008) Origins of Resistance Conferred by the R292K Neuraminidase Mutation via Molecular Dynamics and Free Energy Calculations, J. Chem. Theory Comput. 4, 1526–1540.CrossRefGoogle Scholar
  22. 22.
    Aruksakunwong, O., Malaisree, M., Decha, P., Sompornpisut, P., Parasuk, V., Pianwanit, S., and Hannongbua, S. (2007) On the Lower Susceptibility of Oseltamivir to Influenza Neuraminidase Subtype N1 than Those in N2 and N9, Biophysical Journal 92, 798–807.PubMedCrossRefGoogle Scholar
  23. 23.
    Malaisree, M., Rungrotmongkol, T., Decha, P., Intharathep, P., Aruksakunwong, O., and Hannongbua, S. (2008) Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1, Proteins: Structure, Function, and Bioinformatics 71, 1908–1918.CrossRefGoogle Scholar
  24. 24.
    Wang, P., and Zhang, J. Z. H. (2010) Selective Binding of Antiinfluenza Drugs and Their Analogues to Open and Closed Conformations of H5N1 Neuraminidase, The Journal of Physical Chemistry B 114, 12958–12964.PubMedCrossRefGoogle Scholar
  25. 25.
    Paulsen, J. L., and Anderson, A. C. (2009) Scoring Ensembles of Docked Protein:Ligand Interactions for Virtual Lead Optimization, Journal of Chemical Information and Modeling 49, 2813–2819.PubMedCrossRefGoogle Scholar
  26. 26.
    Lawrenz, M., Baron, R., and McCammon, J. A. (2009) Independent-Trajectories Thermodynamic-Integration Free-Energy Changes for Biomolecular Systems: Determinants of H5N1 Avian Influenza Virus Neuraminidase Inhibition by Peramivir, Journal of Chemical Theory and Computation 5, 1106–1116.PubMedCrossRefGoogle Scholar
  27. 27.
    Wereszczynski, J., and McCammon, J. A. (2010) Using Selectively Applied Accelerated Molecular Dynamics to Enhance Free Energy Calculations, Journal of Chemical Theory and Computation 6, 3285–3292.PubMedCrossRefGoogle Scholar
  28. 28.
    De Clercq, E. (2006) Antiviral agents active against influenza A viruses, Nat Rev Drug Discov 5, 1015–1025.PubMedCrossRefGoogle Scholar
  29. 29.
    Laver, W. G., and Valentine, R. C. (1969) Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus, Virology 38, 105–119.PubMedCrossRefGoogle Scholar
  30. 30.
    Bouvier, N. M., and Palese, P. (2008) The biology of influenza viruses, Vaccine 26, D49–D53.PubMedCrossRefGoogle Scholar
  31. 31.
    Wagner, R., Matrosovich, M., and Klenk, H. D. (2002) Functional balance between haemagglutinin and neuraminidase in influenza virus infections, Rev Med Virol 12, 159–166.PubMedCrossRefGoogle Scholar
  32. 32.
    Markwick, P. R., Cervantes, C. F., Abel, B. L., Komives, E. A., Blackledge, M., and McCammon, J. A. (2010) Enhanced conformational space sampling improves the prediction of chemical shifts in proteins, J Am Chem Soc 132, 1220–1221.PubMedCrossRefGoogle Scholar
  33. 33.
    Russell, R. J., Haire, L. F., Stevens, D. J., Collins, P. J., Lin, Y. P., Blackburn, G. M., Hay, A. J., Gamblin, S. J., and Skehel, J. J. (2006) The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design, Nature 443, 45–49.PubMedCrossRefGoogle Scholar
  34. 34.
    Dubois, R. M., Aguilar-Yanez, J. M., Mendoza-Ochoa, G. I., Oropeza-Almazan, Y., Schultz-Cherry, S., Alvarez, M. M., White, S. W., and Russell, C. J. (2010) The Receptor-Binding Domain of Influenza Virus Hemagglutinin Produced in Escherichia coli Folds into its Native, Immunogenic Structure, J Virol.Google Scholar
  35. 35.
    Russell, R. J., Kerry, P. S., Stevens, D. J., Steinhauer, D. A., Martin, S. R., Gamblin, S. J., and Skehel, J. J. (2008) Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion, Proc Natl Acad Sci U S A 105, 17736–17741.PubMedCrossRefGoogle Scholar
  36. 36.
    Stevens, J., Corper, A. L., Basler, C. F., Taubenberger, J. K., Palese, P., and Wilson, I. A. (2004) Structure of the Uncleaved Human H1 Hemagglutinin from the Extinct 1918 Influenza Virus, Science 303, 1866–1870.PubMedCrossRefGoogle Scholar
  37. 37.
    Wrigley, N. G. (1979) Electron Microscopy of the Influenza Virus, British Medical Bulletin 35, 35–38.PubMedGoogle Scholar
  38. 38.
    Castrucci, M. R., and Kawaoka, Y. (1993) Biologic importance of neuraminidase stalk length in influenza A virus, J. Virol. 67, 759–764.PubMedGoogle Scholar
  39. 39.
    Els, M. C., Air, G. M., Murti, K. G., Webster, R. G., and Laver, W. G. (1985) An 18-amino acid deletion in an influenza neuraminidase, Virology 142, 241–247.PubMedCrossRefGoogle Scholar
  40. 40.
    Chong, A. K., Pegg, M. S., and von Itzstein, M. (1991) Influenza virus sialidase: effect of calcium on steady-state kinetic parameters, Biochim Biophys Acta 1077, 65–71.PubMedCrossRefGoogle Scholar
  41. 41.
    Lawrenz, M., Wereszczynski, J., Amaro, R., Walker, R., Roitberg, A., and McCammon, J. A. (2010) Impact of calcium on N1 influenza neuraminidase dynamics and binding free energy, Proteins 78, 2523–2532.PubMedGoogle Scholar
  42. 42.
    Zhang, L., and Hermans, J. (1996) Hydrophilicity of cavities in proteins, Proteins: Structure, Function, and Genetics 24, 433–438.CrossRefGoogle Scholar
  43. 43.
    Vriend, G. (1990) WHAT IF: a molecular modeling and drug design program, J Mol Graph 8, 52-56, 29.Google Scholar
  44. 44.
    Niesen, F. H., Berglund, H., and Vedadi, M. (2007) The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability, Nat. Protocols 2, 2212–2221.CrossRefGoogle Scholar
  45. 45.
    Li, Q., Qi, J., Zhang, W., Vavricka, C. J., Shi, Y., Wei, J., Feng, E., Shen, J., Chen, J., Liu, D., He, J., Yan, J., Liu, H., Jiang, H., Teng, M., Li, X., and Gao, G. F. (2010) The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site, Nat Struct Mol Biol 17, 1266–1268.PubMedCrossRefGoogle Scholar
  46. 46.
    Rudrawar, S., Dyason, J. C., Rameix-Welti, M.-A., Rose, F. J., Kerry, P. S., Russell, R. J. M., van der Werf, S., Thomson, R. J., Naffakh, N., and von Itzstein, M. (2011) Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase, Nat Commun 1, 113.CrossRefGoogle Scholar
  47. 47.
    Amaro, R. E., Baron, R., and McCammon, J. A. (2008) An improved relaxed complex scheme for receptor flexibility in computer-aided drug design, J Comput Aided Mol Des 22, 693–705.PubMedCrossRefGoogle Scholar
  48. 48.
    Lin, J. H., Perryman, A. L., Schames, J. R., and McCammon, J. A. (2002) Computational drug design accommodating receptor flexibility: the relaxed complex scheme, J Am Chem Soc 124, 5632–5633.PubMedCrossRefGoogle Scholar
  49. 49.
    Ward, C. W., Murray, J. M., Roxburgh, C. M., and Jackson, D. C. (1983) Chemical and antigenic characterization of the carbohydrate side chains of an Asian (N2) influenza virus neuraminidases, Virology 126, 370–375.PubMedCrossRefGoogle Scholar
  50. 50.
    Li, S., Schulman, J., Itamura, S., and Palese, P. (1993) Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus, J Virol 67, 6667–6673.PubMedGoogle Scholar
  51. 51.
    Salisburg, A. M., Deline, A. L., Lexa, K. W., Shields, G. C., and Kirschner, K. N. (2009) Ramachandran-type plots for glycosidic linkages: Examples from molecular dynamic simulations using the Glycam06 force field, J Comput Chem 30, 910–921.PubMedCrossRefGoogle Scholar
  52. 52.
    Kirschner, K. N., Yongye, A. B., Tschampel, S. M., Gonzalez-Outeirino, J., Daniels, C. R., Foley, B. L., and Woods, R. J. (2008) GLYCAM06: a generalizable biomolecular force field. Carbohydrates, J Comput Chem 29, 622–655.PubMedCrossRefGoogle Scholar
  53. 53.
    Skehel, J. J., and Wiley, D. C. (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin, Annu Rev Biochem 69, 531–569.PubMedCrossRefGoogle Scholar
  54. 54.
    Collins, B. E., and Paulson, J. C. (2004) Cell surface biology mediated by low affinity multivalent protein-glycan interactions, Curr Opin Chem Biol 8, 617–625.PubMedCrossRefGoogle Scholar
  55. 55.
    Ha, Y., Stevens, D. J., Skehel, J. J., and Wiley, D. C. (2001) X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs, Proc Natl Acad Sci U S A 98, 11181–11186.PubMedCrossRefGoogle Scholar
  56. 56.
    Chandrasekaran, A., Srinivasan, A., Raman, R., Viswanathan, K., Raguram, S., Tumpey, T. M., Sasisekharan, V., and Sasisekharan, R. (2008) Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin, Nat Biotechnol 26, 107–113.PubMedCrossRefGoogle Scholar
  57. 57.
    Gamblin, S. J., Haire, L. F., Russell, R. J., Stevens, D. J., Xiao, B., Ha, Y., Vasisht, N., Steinhauer, D. A., Daniels, R. S., Elliot, A., Wiley, D. C., and Skehel, J. J. (2004) The structure and receptor binding properties of the 1918 influenza hemagglutinin, Science 303, 1838–1842.PubMedCrossRefGoogle Scholar
  58. 58.
    Eisen, M. B., Sabesan, S., Skehel, J. J., and Wiley, D. C. (1997) Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography, Virology 232, 19–31.PubMedCrossRefGoogle Scholar
  59. 59.
    Tessier, M. B., DeMarco, M. L., Yongye, A. B., and Woods, R. J. (2008) Extension of the GLYCAM06 biomolecular force field to lipids, lipid bilayers and glycolipids, Molecular Simulation 34, 349–364.CrossRefGoogle Scholar
  60. 60.
    Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., and Simmerling, C. (2006) Comparison of multiple Amber force fields and development of improved protein backbone parameters, Proteins 65, 712–725.PubMedCrossRefGoogle Scholar
  61. 61.
    Kuttel, M., Brady, J. W., and Naidoo, K. J. (2002) Carbohydrate solution simulations: Producing a force field with experimentally consistent primary alcohol rotational frequencies and populations, Journal of Computational Chemistry 23, 1236–1243.PubMedCrossRefGoogle Scholar
  62. 62.
    Eklund, R., and Widmalm, G. (2003) Molecular dynamics simulations of an oligosaccharide using a force field modified for carbohydrates, Carbohydrate Research 338, 393–398.PubMedCrossRefGoogle Scholar
  63. 63.
    Guvench, O., Greene, S. N., Kamath, G., Brady, J. W., Venable, R. M., Pastor, R. W., and Mackerell Jr, A. D. (2008) Additive empirical force field for hexopyranose monosaccharides, Journal of Computational Chemistry 29, 2543–2564.PubMedCrossRefGoogle Scholar
  64. 64.
    Kamath, G., Guvench, O., and MacKerell, A. D. (2008) CHARMM Additive All-Atom Force Field for Acyclic Carbohydrates and Inositol, Journal of Chemical Theory and Computation 4, 1990–1990.CrossRefGoogle Scholar
  65. 65.
    MacKerell, A., Bashford, D., Bellot, M., Dunbrack, R., Evanseck, J., Field, M., Fischer, S., Gao, J., Guo, H., Ha, S., Joseph-McCarthy, D., Kuchnir, L., Kuczera, K., Lau, F., Mattos, C., Michnick, S., Ngo, T., Nguyen, D., Prodhom, B., Reither, W., III, Roux, B., Schlenkrich, M., Smith, J., Stote, R., Straub, J., Watanabe, M., Wiorkiewicz-Kuczera, J., and Karplus, M. (1998) All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins, J. Phys. Chem. B. 102, 3586–3616.CrossRefGoogle Scholar
  66. 66.
    Frank, M., and Lieth, C. W. (1997) Comparison of the Conformational Behavior of Sialyllactose Complexed with the two Viral Attachment Proteins Influenza A Hemagglutinin and the Murine Polyomavirus J. Mol. Model. 3, 408–414.CrossRefGoogle Scholar
  67. 67.
    Li, M., and Wang, B. (2006) Computational studies of H5N1 hemagglutinin binding with SA-alpha-2, 3-Gal and SA-alpha-2, 6-Gal, Biochem Biophys Res Commun 347, 662–668.PubMedCrossRefGoogle Scholar
  68. 68.
    Auewarakul, P., Suptawiwat, O., Kongchanagul, A., Sangma, C., Suzuki, Y., Ungchusak, K., Louisirirotchanakul, S., Lerdsamran, H., Pooruk, P., Thitithanyanont, A., Pittayawonganon, C., Guo, C. T., Hiramatsu, H., Jampangern, W., Chunsutthiwat, S., and Puthavathana, P. (2007) An Avian Influenza H5N1 Virus That Binds to a Human-Type Receptor, J Virol 81, 9950–9955.PubMedCrossRefGoogle Scholar
  69. 69.
    Xu, D., Newhouse, E. I., Amaro, R. E., Pao, H. C., Cheng, L. S., Markwick, P. R. L., McCammon, J. A., Li, W. W., and Arzberger, P. W. (2009) Distinct Glycan Topology for Avian and Human Sialopentasaccharide Receptor Analogues upon Binding Different Hemagglutinins: A Molecular Dynamics Perspective, Journal of Molecular Biology 387, 465–491.PubMedCrossRefGoogle Scholar
  70. 70.
    Sauter, N. K., Bednarski, M. D., Wurzburg, B. A., Hanson, J. E., Whitesides, G. M., Skehel, J. J., and Wiley, D. C. (1989) Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study, Biochemistry 28, 8388–8396.PubMedCrossRefGoogle Scholar
  71. 71.
    Mochalova, L., A. Gambaryan, J. Romanova, A. Tuzikov, A. Chinarev, D. Katinger, H. Katinger, A. Egorov, and N. Bovin. (2003) Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs, Virology 313, 473–480.PubMedCrossRefGoogle Scholar
  72. 72.
    Sauter, N. K., Hanson, J. E., Glick, G. D., Brown, J. H., Crowther, R. L., Park, S. J., Skehel, J. J., and Wiley, D. C. (1992) Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography, Biochemistry 31, 9609–9621.PubMedCrossRefGoogle Scholar
  73. 73.
    Hanson, J. E., N. K. Sauter, J. J. Skehel, and D. C. Wiley. (1992) Proton nuclear magnetic resonance studies of the binding of sialosides to intact influenza virus, Virology 189, 525–533.PubMedCrossRefGoogle Scholar
  74. 74.
    Glick, G. D., P. L. Toogood, D. C. Wiley, J. J. Skehel, and J. R. Knowles. (1991) Ligand recognition by influenza virus. The binding of bivalent sialosides, Biochemistry 266, 23660–23669.Google Scholar
  75. 75.
    Takemoto, D. K., J. J. Skehel, and D. Wiley. (1996) A Surface Plasmon Resonance Assay for the Binding of Influenza Virus Hemagglutinin to Its Sialic Acid Receptor, Virology 217, 452–458.PubMedCrossRefGoogle Scholar
  76. 76.
    Critchley, P., and N. J. Dimmock. (2004) Binding of an influenza A virus to a neomembrane measured by surface plasmon resonance, Bioorganic & Medicinal Chemistry 12, 2773–2780.CrossRefGoogle Scholar
  77. 77.
    Hidari, K. I., Shimada, S., Suzuki, Y., and Suzuki, T. (2007) Binding kinetics of influenza viruses to sialic acid-containing carbohydrates, Glycoconj J 24, 583–590.PubMedCrossRefGoogle Scholar
  78. 78.
    Toone, E. J. (1994) Structure and energetics of protein-carbohydrate complexes, Curr. Opin. Struct. Biol 4, 719–728.CrossRefGoogle Scholar
  79. 79.
    Ambrosi, M., N. R. Cameron, and B. G. Davis. (2005) Lectins: tools for the molecular understanding of the glycocode, Organic & Biomolecular Chemistry 3, 1593–1608.CrossRefGoogle Scholar
  80. 80.
    Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kale, L., and Schulten, K. (2005) Scalable molecular dynamics with NAMD, J Comput Chem 26, 1781–1802.PubMedCrossRefGoogle Scholar
  81. 81.
    Case, D. A., Cheatham, T. E., 3rd, Darden, T., Gohlke, H., Luo, R., Merz, K. M., Jr., Onufriev, A., Simmerling, C., Wang, B., and Woods, R. J. (2005) The Amber biomolecular simulation programs, J Comput Chem 26, 1668–1688.PubMedCrossRefGoogle Scholar
  82. 82.
    Christen, T., Hunenberger, P. H., Bakowies, D., Baron, R., Burgi, R., Geerke, D. P., Heinz, T. N., Kastenholz, M. A., Krautler, V., Oostenbrink, C., Peter, C., Trzesniak, D., and Van Gunsteren, W. F. (2005) The GROMOS software for biomolecular simulation: GROMOS05, Journal of Computational Chemistry 26, 1719–1751.PubMedCrossRefGoogle Scholar
  83. 83.
    Hess, B., Kutzner, C., van der Spoel, D., and Lindahl, E. (2008) GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation, Journal of Chemical Theory and Computation 4, 435–447.CrossRefGoogle Scholar
  84. 84.
    Bowers, K. J., Chow, E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., Klepeis, J. L., Kolossvary, I., Moraes, M. A., Sacerdoti, F. D., Salmon, J. K., Shan, Y., and Shaw, D. E. (2006) Scalable algorithms for molecular dynamics simulations on commodity clusters, In Proceedings of the 2006 ACM/IEEE conference on Supercomputing, p 84, ACM, Tampa, Florida.Google Scholar
  85. 85.
    Kasson, P. M., Lindahl, E., and Pande, V. S. (2010) Atomic-Resolution Simulations Predict a Transition State for Vesicle Fusion Defined by Contact of a Few Lipid Tails, PLoS Comput Biol 6, e1000829.PubMedCrossRefGoogle Scholar
  86. 86.
    Darden, T., York, D., and Pedersen, L. (1993) Particle mesh Ewald: An N [center-dot] log(N) method for Ewald sums in large systems, The Journal of Chemical Physics 98, 10089–10092.CrossRefGoogle Scholar
  87. 87.
    Gabdoulline, R. R., and Wade, R. C. (2009) On the Contributions of Diffusion and Thermal Activation to Electron Transfer between Phormidium laminosum Plastocyanin and Cytochrome f: Brownian Dynamics Simulations with Explicit Modeling of Nonpolar Desolvation Interactions and Electron Transfer Events, Journal of the American Chemical Society 131, 9230–9238.PubMedCrossRefGoogle Scholar
  88. 88.
    Birch, L., Murray, C. W., Hartshorn, M. J., Tickle, I. J., and Verdonk, M. L. (2002) Sensitivity of molecular docking to induced fit effects in influenza virus neuraminidase, Journal of Computer-Aided Molecular Design 16, 855–869.PubMedCrossRefGoogle Scholar
  89. 89.
    Mukherjee, S., Balius, T. E., and Rizzo, R. C. (2010) Docking Validation Resources: Protein Family and Ligand Flexibility Experiments, Journal of Chemical Information and Modeling 50, 1986–2000.PubMedCrossRefGoogle Scholar
  90. 90.
    Sun, J., Cai, S., Yan, N., and Mei, H. (2010) Docking and 3D-QSAR studies of influenza neuraminidase inhibitors using three-dimensional holographic vector of atomic interaction field analysis, European Journal of Medicinal Chemistry 45, 1008–1014.PubMedCrossRefGoogle Scholar
  91. 91.
    Abu Hammad, A. M., Afifi, F. U., and Taha, M. O. (2007) Combining docking, scoring and molecular field analyses to probe influenza neuraminidase-ligand interactions, Journal of Molecular Graphics and Modelling 26, 443–456.PubMedCrossRefGoogle Scholar
  92. 92.
    Rungrotmongkol, T., Intharathep, P., Malaisree, M., Nunthaboot, N., Kaiyawet, N., Sompornpisut, P., Payungporn, S., Poovorawan, Y., and Hannongbua, S. (2009) Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus, Biochemical and Biophysical Research Communications 385, 390–394.PubMedCrossRefGoogle Scholar
  93. 93.
    Bush, R. (2011) Influenza Forensics, In Microbial Forensics (Budowle, B., Schutzer, S. E., Breeze, R. G., Keim, P. S., and Morse, S. A., Eds.) Second Edition ed., pp 109-135, Elsevier, Inc.Google Scholar
  94. 94.
    Huey, R., Morris, G. M., Olson, A. J., and Goodsell, D. S. (2007) A semiempirical free energy force field with charge-based desolvation, J Comput Chem 28, 1145–1152.PubMedCrossRefGoogle Scholar
  95. 95.
    Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., and Olson, A. J. (1998) Automated Docking Using a Lamarckian Genetic Algorithm and an Empirical Binding Free Energy Function, Journal of Computational Chemistry 19, 1639–1662.CrossRefGoogle Scholar
  96. 96.
    Dolinsky, T. J., Czodrowski, P., Li, H., Nielsen, J. E., Jensen, J. H., Klebe, G., and Baker, N. A. (2007) PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations, Nucleic Acids Res 35, W522–525.PubMedCrossRefGoogle Scholar
  97. 97.
    Landon, M., Amaro, R., Baron, R., McCammon, J. A., and Vadja, S. (2008) Novel Druggable Hot Spots in Avian Influenza Neuraminidase Revealed by Computational Solvent Mapping of a Reduced and Representative Receptor Ensemble, Chemical Biology & Drug Design 71, 106–116.CrossRefGoogle Scholar
  98. 98.
    Schrodinger, L. (2009) Maestro, New York, NY.Google Scholar
  99. 99.
    Shao, J., S. W. Tanner, N. Thompson, and T. E. Cheatham. (2007) Clustering Molecular Dynamics Trajectories: 1. Characterizing the Performance of Different Clustering Algorithms, J. Chem. Theory Comput 3, 2312–2334.CrossRefGoogle Scholar
  100. 100.
    Kadirvelraj, R., Gonzalez-Outeirino, J., Foley, B. L., Beckham, M. L., Jennings, H. J., Foote, S., Ford, M. G., and Woods, R. J. (2006) Understanding the bacterial polysaccharide antigenicity of Streptococcus agalactiae versus Streptococcus pneumoniae, Proceedings of the National Academy of Sciences 103, 8149–8154.CrossRefGoogle Scholar
  101. 101.
    Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., and Ferrin, T. E. (2004) UCSF Chimera--a visualization system for exploratory research and analysis, J Comput Chem 25, 1605–1612.PubMedCrossRefGoogle Scholar
  102. 102.
    Humphrey, W., Dalke, A., and Schulten, K. (1996) VMD: visual molecular dynamics, J Mol Graph 14, 33-38, 27–38.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Departments of Pharmaceutical Sciences, Computer Science, and ChemistryUniversity of CaliforniaIrvineUSA
  2. 2.National Biomedical Computation ResourceUniversity of California, San DiegoLa JollaUSA

Personalised recommendations